These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6291539)

  • 1. The interaction of miconazole and ketoconazole with lipids.
    Van den Bossche H; Ruysschaert JM; Defrise-Quertain F; Willemsens G; Cornelissen F; Marichal P; Cools W; Van Cutsem J
    Biochem Pharmacol; 1982 Aug; 31(16):2609-17. PubMed ID: 6291539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic action of lipid components of membranes from Candida albicans and various other lipids on two imidazole antimycotics, clotrimazole and miconazole.
    Yamaguchi H
    Antimicrob Agents Chemother; 1977 Jul; 12(1):16-25. PubMed ID: 329757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention by L-alpha-phosphatidylcholine of antifungal activity in vitro of liposome-encapsulated imidazoles determined by using time-killing curves.
    De Logu A; Fadda AM; Pellerano ML; Diana G; Schivo ML
    Int J Antimicrob Agents; 2000 Jun; 15(1):43-8. PubMed ID: 10856676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.
    Georgopapadakou NH; Dix BA; Smith SA; Freudenberger J; Funke PT
    Antimicrob Agents Chemother; 1987 Jan; 31(1):46-51. PubMed ID: 3551826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of antifungal imidazoles on Staphylococcus aureus.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1982 Sep; 22(3):470-4. PubMed ID: 6291453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of insertion of miconazole, ketoconazole and deacylated ketoconazole in lipid layers. A conformational analysis.
    Brasseur R; Vandenbosch C; Van den Bossche H; Ruysschaert JM
    Biochem Pharmacol; 1983 Jul; 32(14):2175-80. PubMed ID: 6307314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action.
    Vanden Bossche H
    Curr Top Med Mycol; 1985; 1():313-51. PubMed ID: 3916772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of action of the new antimycotic ketoconazole.
    Borgers M; Van den Bossche H; De Brabander M
    Am J Med; 1983 Jan; 74(1B):2-8. PubMed ID: 6295147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.
    Beggs WH
    Antimicrob Agents Chemother; 1984 Mar; 25(3):316-8. PubMed ID: 6326664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole.
    Borgers M; De Brabander M; Van Den Bossche H; Van Cutsem J
    Postgrad Med J; 1979 Sep; 55(647):687-91. PubMed ID: 392485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations.
    De Logu A; Fadda AM; Anchisi C; Maccioni AM; Sinico C; Schivo ML; Alhaique F
    J Antimicrob Chemother; 1997 Dec; 40(6):889-93. PubMed ID: 9462444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Oct; 134(4):336-41. PubMed ID: 789787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species.
    Beggs WH
    J Antimicrob Chemother; 1983 Apr; 11(4):381-3. PubMed ID: 6304001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum.
    Pershing LK; Corlett J; Jorgensen C
    Antimicrob Agents Chemother; 1994 Jan; 38(1):90-5. PubMed ID: 8141586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hyphal development in Trichophyton mentagrophytes arthroconidia by ketoconazole and miconazole.
    Scott EM; Gorman SP; McGrath SJ
    J Antimicrob Chemother; 1985 Apr; 15(4):405-15. PubMed ID: 4008375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole.
    Rautemaa R; Richardson M; Pfaller M; Perheentupa J; Saxen H
    Scand J Infect Dis; 2008; 40(11-12):904-7. PubMed ID: 18651265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological perspective of ketoconazole.
    Strippoli V; Lucchetti G; Simonetti N
    Chemioterapia; 1986 Apr; 5(2):120-4. PubMed ID: 3518964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of inhibition of sterol synthesis with growth-inhibitory action of imidazole antimycotics in Candida albicans.
    Nicholas RO; Kerridge D
    J Antimicrob Chemother; 1989 Jan; 23(1):7-19. PubMed ID: 2663807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of supplementation of ergosterol on miconazole action in vivo and in vitro in Candida albicans.
    Mago N; Khuller GK
    Indian J Exp Biol; 1991 Sep; 29(9):841-4. PubMed ID: 1794867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by unsaturated lecithin against the imidazole antimycotics, clotrimazole and miconazole.
    Yamaguchi H
    Antimicrob Agents Chemother; 1978 Mar; 13(3):423-6. PubMed ID: 400822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.